08:00 Registration
08.30 MedEA Welcome
Robert Fischer, Germany
08.40 Local welcome
Pedro Xavier, Portugal
08.50 Introduction and objectives
Sandro C. Esteves, Brazil
08.55 Keynote Lecture:
Poseidon, Medea, and approaches to fertility in ancient Greek mythology
Nina Papathanasopoulou, Greece
> Session I: The WHY and the WHAT
The Birth of Poseidon
Chairs: Filippo M. Ubaldi, Italy / Joaquín Llacer, Spain
09.35 L1 Why we need new criteria for low prognosis patients: a historical overview
Carlo Alviggi, Italy
09.55 L2 The POSEIDON criteria explained
Robert Fischer, Germany
10.15 Polling questions
Carlo Alviggi, Italy
10.20 Doctor’s perspective
Habib Midassi, Tunisia
10.25 Discussion
10.40 Coffee-break
>Session II: POSEIDON CRITERIA BIOMARKERS
The Nature of Poseidon
Chairs: Michael Dahan, Canada / Carlo Alviggi, Italy
11.10 L3 Female age, oocyte and embryo competence: relevance for the POSEIDON criteria
Filippo M. Ubaldi, Italy
11.30 L4 Antral follicle count and anti-Mullerian hormone for patient classification under the POSEIDON criteria
Antonio La Marca, Italy
11.50 L5 The oocyte number and the relationship with low prognosis
Sesh K. Sunkara, UK
12.10 Polling questions
12.20 Psychologist’s perspective on the role of a classification system for low prognosis patients and the role of female age in reproductive success
(to be announced)
12.25 Discussion
12.45 Lunch
>Session III: POSEIDON METRICS
The Potency of Poseidon
Chairs: Robert Fischer, Germany / Amina Oumeziane, Algeria
14.15 L6 Ovarian hypo-response to COS and its proposed metrics: The FORT and the FOI
Alessandro Conforti, Italy
14.35 L7 The ART calculator: a validated tool to predict reproductive success in ART
Sandro C. Esteves, Brazil
14.55 Polling questions
15.05 Patient’s perspective
15.10 Discussion
> Session IV: LESSONS FROM REAL-WORLD DATA RESEARCH
Stories of Poseidon
Chairs: Margarida Silvestre, Portugal; Sesh K. Sunkara, UK
15.30 L8 POSEIDON in clinical practice: prevalence and patient characteristics
Hakan Yarali, Turkey
15.50 L9 Cumulative Live Birth Rates in POSEIDON patients
Sandro C. Esteves, Brazil
16.10 Clinician’s perspective.
(to be announced)
16.15 Polling questions
16.25 Nutrition and exercise
Maria Giulia Minasi, Italy
16.30 Discussion
16.45 Closing of the first day
Carlo Alviggi, Italy
> Session V: Clinical Utility
Poseidon as Protector
Chairs: Budi Wiweko, Indonesia / Ariel Weissman, Israel
09.00 Introduction to the second day
Sandro C. Esteves, Brazil
09.05 The protection of nature by Archipelagos
Sandro C Esteves, Brazil
09.10 L10 Management strategies in POSEIDON groups 1 and 2 patients
Klaus Bühler, Germany
09.30 Polling questions, case scenarios and panel discussion
Presenter: K. Bühler
Panelists: C. Alviggi, A. La Marca, J. Llacer A. Oumeziane, B. Wiweko & A. Weissman
10.05 L11 Management strategies in POSEIDON groups 3 and 4 patients
Robert Fischer, Germany
10.25 Polling questions, case scenarios and panel discussion
Presenter: R. Fischer
Panelists: F. M. Ubaldi, M. Dahan; H. Yarali, S. Sunkara
11.00 Nurse’s perspective
Valerie Peddie, UK
11.05 Coffee-break
> Session VI: Research and Future Perspectives
Poseidon the Earthshaker
Chairs: Pedro Xavier, Portugal / Sandro C. Esteves, Brazil
11.40 L12 The POSORT guidelines: improving study design and reporting of clinical trials
Raoul Orvieto, Israel
12.00 L13 Frontiers in Endocrinology research topic
Claus Yding Andersen, Denmark
12.05 L14 The POSEIDON group: what did we achieve and what’s next?
Carlo Alviggi, Italy
12.25 Panel discussion
Orvieto, Israel; C. Alviggi, Italy; H. Yarali, Turkey; F Ubaldi, Italy; M. Dahan, Canada: S. Sunkara, UK
12.55 Concluding remarks
Robert Fischer, Germany
13.00 End of the conference
Pedro Xavier, Portugal
13.05 Closing Lunch